Evidence map›Paper›PMID 41459860›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Tempeh Extract and HSC-3 Cell Migration: An In Vitro Study.

Rahmi Amtha, Shirley Tjhie, Firstine Kelsi Hartanto, Ria Aryani Hayuningtyas, Indrayadi Gunardi, Haizal Hussaini

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rahmi AmthaDepartment of Oral Medicine, Faculty of Dentistry, Universitas Trisakti, Jakarta, Indonesia.ORCID 0000-0002-0884-0325
Shirley TjhieFaculty of Dentistry, Universitas Trisakti, Jakarta, Indonesia.
Firstine Kelsi HartantoDepartment of Oral Medicine, Faculty of Dentistry, Universitas Trisakti, Jakarta, Indonesia.ORCID 0000-0002-2672-4635
Ria Aryani HayuningtyasDepartment of Oral Biology, Faculty of Dentistry, Universitas Trisakti, Jakarta, Indonesia.
Indrayadi GunardiDepartment of Oral Medicine, Faculty of Dentistry, Universitas Trisakti, Jakarta, Indonesia.ORCID 0009-0009-8955-4459
Haizal HussainiDepartment of Oral Diagnostic and Surgical Sciences, Faculty of Dentistry, University of Otago, New Zealand.ORCID 0000-0002-5005-5224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the migration capacity of HSC-3 cells following treatment with various concentrations of tempeh extract.

methodsThis laboratory-based study using HSC-3 cell lines, which were treated with tempeh extract (SNI-3144:2015) dissolved in either 70% ethanol or water at concentrations of 25, 50, 100, 200, and 400 μg/mL. Cell migration was assessed using a scratch assay at 6 and 24 hours, conducted in triplicate. Data were analyzed using ANOVA and Kruskal-Wallis tests.

resultAt the 6-hour observation point, no significant differences in migration were observed between groups for either solvent (p>0.05). However, after 24 hours, the 50 μg/mL group (6.88±11.92) demonstrated the largest scratch area compared with other concentrations (p<0.033).

conclusionTempeh extract showed no inhibitory effect on HSC-3 cell migration when compared to doxorubicin, particularly when water was used as the solvent. Further research is needed with higher concentrations of tempeh extract to evaluate its potential inhibitory effects on HSC-3 cell migration.

Indexed as

Cell MovementPlant ExtractsCell ProliferationHumansTumor Cells, CulturedPlant ExtractsHSC-3migrationoral squamous cell carcinomaTempeh extract

Identifiers

PMID41459860
PMCPMC13242545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.